Hemispherx Biopharma (AMEX: HEB) announced that a federal judge in Delaware has dismissed all claims against Hemispherx and the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE